On April 19, the XDAO Foundation announced that the Singaporean NFT sports platform XRUN, which was previously created in April 2022, had its shares fully acquired by an encryption foundation in Southeast Asia and initiated project restructuring. The cryptocurrency funds jointly participated in a new round of strategic financing, and the specific terms of the transaction have not yet been disclosed. New investors are very optimistic about the future of the sports and health sector in the web3 field, and they are also very optimistic about the development prospects of platforms that focus on deep farming technologies in the web3 field.
The brand upgrade of the whole platform is carried out at the same time, from XRUN to FitVerse, and the new brand will better reflect the mission and values. FitVerse simultaneously launched the APP upgrade iteration, and provided better service and experience for the majority of users, opening a new era of sports.
It is reported that XRUN is a completely independent operating company registered in the United States, Singapore, South Africa, Seychelles and other places, founded by Jordan, an early contributor to People. In 2022, XRUN received a cumulative million-dollar investment from many top web3 institutions and founders of well-known companies, including BlockACE Capital in Asia Pacific, Bitin Capital, Newave Capital in Singapore, Block Patch in South Korea, Skyline Capita in the UK, and Robot Cat Capital.
Media contact:
Contact Person: John
Company Name: xrun
Address: United States
Website: xrun.world
Email: John@xrun.world
This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.